MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research
- 1 January 2007
- journal article
- review article
- Published by Wiley in Drug and Alcohol Review
- Vol. 26 (1), 9-15
- https://doi.org/10.1080/09595230601036945
Abstract
The substituted amphetamines 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) and methamphetamine (METH, ‘ice’, ‘speed’) are increasingly popular drugs amongst party‐drug users. Studies with humans have investigated the acute and possible long‐term adverse effects of these drugs, yet outcomes of such studies are often ambiguous due to a variety of confounding factors. Studies employing animal models have value in determining the acute and long‐term effects of MDMA and METH on brain and behaviour. Self‐administration studies show that intravenous METH is a particularly potent reinforcer in rats and other species. In contrast, MDMA appears to have powerful effects in enhancing social behaviour in laboratory animals. Brief exposure to MDMA or METH may produce long‐term reductions in dopamine, serotonin and noradrenaline in the brain and alterations in the density of various receptor and transporter proteins. However it is still unclear, particularly in the case of MDMA, whether this reflects a ‘neurotoxic’ effect of the drug. Lasting alterations in social behaviour, anxiety, depressive symptoms and memory have been demonstrated in laboratory rats given MDMA or METH and this matches long‐term changes reported in some human studies. Recent laboratory studies suggest that MDMA/METH combinations may produce greater adverse neurochemical and behavioural effects than either drug alone. This is of some concern given recent evidence that party drug users may be frequently exposed to this combination of drugs.Keywords
This publication has 63 references indexed in Scilit:
- Intravenous methamphetamine self-administration in rats: Effects of intravenous or intraperitoneal MDMA co-administrationPharmacology Biochemistry and Behavior, 2006
- The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overviewJournal of Psychopharmacology, 2006
- MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stressJournal of Psychopharmacology, 2006
- Recreational ecstasy use and depressionJournal of Psychopharmacology, 2005
- Pharmacotherapy and other treatments for cocaine abuse and dependenceCurrent Opinion in Psychiatry, 2005
- Patterns of Simultaneous Polysubstance Use in Canadian Rave AttendeesSubstance Use & Misuse, 2005
- Structural Abnormalities in the Brains of Human Subjects Who Use MethamphetamineJournal of Neuroscience, 2004
- Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivativesBehavioural Pharmacology, 2003
- Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatumJournal of Neural Transmission, 2001
- MDMA and Learning: Effects of Acute and Neurotoxic Exposure in the RatPharmacology Biochemistry and Behavior, 2000